Baudax Bio Financials

Baudax Bio Stock Summary

Baudax Bio competes with Virax Biolabs, Palisade Bio, Allarity Therapeutics, Cns Pharmaceuticals, and Windtree Therapeutics. Baudax Bio, Inc., a pharmaceutical company, develops and commercializes products for hospital and other acute care settings. The company was incorporated in 2019 and is based in Malvern, Pennsylvania. Baudax Bio operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 80 people.

Baudax Bio Key Financial Ratios

Baudax Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Baudax Bio's current stock value. Our valuation model uses many indicators to compare Baudax Bio value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Baudax Bio competition to find correlations between indicators driving Baudax Bio's intrinsic value. More Info.Baudax Bio is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Baudax Bio's earnings, one of the primary drivers of an investment's value.

Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.

If you are still planning to invest in Baudax Bio check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Baudax Bio's history and understand the potential risks before investing.